Prognostic and Predictive Value of Non-Steroidal Anti-Inflammatory Drugs in the EORTC 1325/KEYNOTE-054 Phase III Trial of Pembrolizumab Versus Placebo in Resected High-Risk Stage III Melanoma.
European Journal of Cancer（2024）
关键词
Immunotherapy,Immune checkpoint inhibitors,Pembrolizumab,Melanoma,Non-steroidal anti-inflammatory drugs,Cyclooxygenase inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要